Skip to main content
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
1.R. I. Levy, “Prevalence and epidemiology of cardiovascular disease,” in Textbook of Medicine, edited by P. B. Beeson, W. McDermott, and J. B. Wyngaarden (Saunders, Philadelphia, 1979), pp. 1059–1063.
2.S. J. Pocock, R. A. Henderson, A. F. Rickards et al., “Meta analysis of randomized trials comparing coronary angioplasty with bypass surgery,” Lancet 346, 11841189 (1995).
3.W. S. Weintraub, P. D. Mauldin, E. Becker, A. S. Kosinski, and S. B. King , III, “A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory angioplasty versus surgery trial,” Circulation 92, 28312840 (1995).
4.P. W. Serruys, P. deJaegere, F. Kiemeneij et al., “A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease,” New England J. Med. 331, 489495 (1994).
5.D. L. Fischman, M. B. Leon, D. S. Baim et al., “A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease,” New England J. Med. 331, 496501 (1994).
6.R. Waksman, “Radiation for prevention of restenosis: where are we?,” Int. J. Radiat. Oncol., Biol., Phys. 36, 959961 (1996).
7.W. D. Edwards, “Atherosclerotic plaques: natural and unnatural history,” in Cardiovascular Pathology Clinicopathologic Correlations and Pathogenetic Mechanisms, edited by F. J. Schoen and M. A. Gimbrone (Williams & Wilkins, Baltimore, MD, 1995).
8.S. E. Nissen, J. C. Gurley, C. L. Grines, D. C. Booth, R. McClure, M. Berk, C. Fischer, and A. N. DeMaria, “Intravascular ultrasound assessment of lumen size and wall morphology of normal subjects and patients with coronary artery disease,” Circulation 84, 10871099 (1991).
9.J. J. Popma, G. S. Mintz, L. F. Satler et al., “Clinical and angiographic outcome after directional atherectomy: a qualitative and quantitative ultrasound,” Am. J. Cardiol. 72, 55E64E (1993).
10.G. S. Mintz, A. D. Pichard, J. A. Kovach, K. M. Kent, L. F. Satler, S. P. Javier, J. J. Popma, and M. B. Leon, “Intravascular ultrasound imaging in planning transcatheter treatment strategies in coronary artery disease,” Am. J. Cardiol. 73, 423430 (1994).
11.S. Nakamura, A. Colombo, A. Gaglione, Y. Almagor, S. L. Goldberg, L. Maiello, L. Finci, and J. M. Tobis, “Comparison of angiography and ultrasound in stent implantation,” Circulation 89, 20262034 (1994).
12.P. Yock, P. Fitzgerald, and R. Popp, “Intravascular ultrasound,” Sci. Med. Sept/Oct, 68–77 (1995).
13.S. B. King, “Restenosis after angioplasty,” in Vascular Brachytherapy, edited by R. Waksman, S. B. King, I. R. Crocker, and R. F. Mould, Nucletron Corp. 1996, pp. 1–8.
14.G. S. Mintz, A. D. Pichard, K. Kent et al., “Endovascular stents reduce restenosis by eliminating geometric arterial remodeling: a serial intravascular ultrasound study,” J. Am. Coll. Cardiol. 35A, 701705 (1995).
15.A. C. Waltman, A. J. Greenfield, R. A. Noveline, W. M. Abbott, D. C. Brewster, R. C. Darling, A. C. Moncure, L. W. Ottinger, and C. A. Athanasoulis, “Transluminal angioplasty of the iliac and femoropopliteal arteries: current status,” Arch. Surg. 117, 12181221 (1982).
16.R. R. Murray , Jr., R. C. Hewes, R. I. White , Jr. et al., “Long-segment femoropopliteal stenoses: is angioplasty a boon or bust?,” Radiology 162, 473476 (1987).
17.M. G. Hunink, M. C. Donaldson, M. F. Meyerovitz et al., “Risks and benefits of femoropopliteal percutaneous balloon angioplasty,” J. Vasc. Surg. 17, 183194 (1993).
18.G. F. White, S. C. Liew, R. C. Waugh et al., “Early outcome of intermediate follow-up of vascular stents in the femoral and popliteal arteries without long term anticoagulation,” J. Vasc. Surg. 21, 279281 (1995).
19.M. A. H. Cohen, D. A. Kumpe, J. D. Durham, and S. C. Zwerdlinger, “Improved treatment of thrombosed hemodialysis access sites with thrombolysis and angioplasty,” Kidney Int. 46, 13751380 (1994).
20.J. T. Dawson, “Theoretical considerations regarding low-dose radiation therapy for prevention of restenosis after angioplasty,” Texas Heart Inst. J. 18, 47 (1991).
21.M. Friedman (private communication).
22.R. S. Schwartz, T. M. Koval, W. D. Edwards, A. R. Camrud, K. R. Bailey, K. Browne, R. E. Vlietstra, and D. R. Holmse, “Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury,” J. Am. Coll. Cardiol. 19, 11061113 (1992).
23.J. Gellman, G. Healey, Q. Chen, M. J. Tselentakis, S. L. Sigal, J. T. Dawson, S. E. Downing, and M. D. Ezekowitz, “The effect of very low dose irradiation on restenosis following balloon angioplasty: a study in the atherosclerotic rabbit,” Circulation 84, II331 (1991) (abstract).
24.A. Shefer, N. L. Eigler, J. S. Whiting, and F. I. Litvack, “Suppression of intimal proliferation after balloon angioplasty with local beta irradiation in rabbits,” J. Am. Coll. Cardiol. 21, 185A (1993) (abstract).
25.M. A. Abbas, N. A. Afshari, M. L. Stadius, R. S. Kernoff, and T. A. Fischell, “External beam irradiation inhibits neointimal hyperplasia following balloon angioplasty,” Int. J. Cardiol. 44, 191202 (1994).
26.S. Shimotakahara and A. R. Mayberg, “Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury,” Stroke 25, 424428 (1994).
27.T. Hirai, Y. Korogi, M. Harada, and M. Takahashi, “Intimal hyperplasia in an atherosclerotic model: prevention with radiation therapy,” Radiology 193, 270 (1994) (abstract).
28.W.-J. Koh, M. R. Mayberg, J. Chambers, K. L. Lindsley, A. Tran, J. S. Rasey, and T. W. Griffin, “The potential role of external beam radiation in preventing restenosis after coronary angioplasty,” Int. J. Radiat. Oncol., Biol., Phys. 36, 829834 (1996).
29.J. G. Wiedermann, C. Marboe, H. Amols, A. Schwartz, and J. Weinberger, “Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model,” J. Am. Coll. Cardiol. 23, 14911498 (1994).
30.J. G. Wiedermann, C. Marboe, H. Amols, A. Schwartz, and J. Weinberger, “Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up,” J. Am. Coll. Cardiol. 25, 14511456 (1995).
31.J. Weinberger, H. Amols, R. D. Ennis, A. Schwartz, J. G. Wiedermann, and C. Marboe, “Intracoronary irradiation: dose response for the prevention of restenosis in swine,” Int. J. Radiat. Oncol., Biol., Phys. 36, 767775 (1996).
32.R. Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, G. D. Cipolla, and S. B. King , III, “Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine,” Circulation 91, 15331539 (1995).
33.R. Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, S. J. Palmer, C. Wang, G. D. Cipolla, and S. B. King , III, “Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries,” Circulation 92, 13831386 (1995).
34.W. Mazur, M. N. Ali, M. M. Khan et al., “High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses,” Int. J. Radiat. Oncol., Biol., Phys. 36, 777788 (1996).
35.V. Verin, Y. Popowski, P. Urban et al., “Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model,” Circulation 92, 22842290 (1995).
36.V. Verin, Y. Popowski, P. Urban et al., “Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model,” J. Am. Coll. Cardiol. 2A, 407406 (1995).
37.R. Waksman, K. A. Robinson, I. R. Crocker, C. Wang, M. B. Gravanis, G. D. Cipolla, R. A. Hillstead, and S. B. King , III, “Intracoronary low dose beta irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model,” Circulation 92, 30253031 (1995).
38.C. Hehrlein, C. Gollan, K. Dönges, J. Metz, R. Riessen, P. Fehsenfeld, E. von Hodenberg, and W. Kübler, “Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperlasia in rabbits,” Circulation 92, 15701575 (1995).
39.J. R. Laird, A. J. Carter, W. Kufs et al., “Inhibition of neointimal proliferation with a beta particle emitting stent,” Circulation 93, 529536 (1996).
40.D. Liermann, H. D. Bottcher, J. Kollath, B. Schopohl, G. Strassman, P. Strecher, and K. H. Breddini, “Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries,” Cardiovasc. Intervent. Radiol. 17, 1216 (1994).
41.B. Schopohl, D. Liermann, L. J. Pohlit, R. Heyd, G. Strassmann, R. Bauersachs, D. Schulte-Huermann, C. G. Rahl, K.-H. Manegold, J. Kollath, and H. D. Bottcher, “ endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience,” Int. J. Radiat. Oncol., Biol., Phys. 36, 835840 (1996).
42.B. Steidle, “Preventative percutaneous radiotherapy for avoiding hyperplasia of the intima following angioplasty together with stent implantation,” Strahlenther. Onkol. 170, 151154 (1994).
43.R. Waksman, I. R. Crocker, D. Kikeri, A. B. Lumsden, J. M. MacDonald, J. Long, S. B. King, III, and L. G. Martin, “Endovascular low dose radiation for prevention of restenosis following angioplasty for treatment of narrowed dialysis arteriovenous graft,” Discoveries in Radiation for Restenosis Workshop, Emory University, Atlanta, GA, 1996 (abstract).
44.J. A. Condado, O. Gurdiel, R. Espinoza, J. G. Brito, M. L. Harrison, L. R. Joyner, and S. F. Liprie, “Percutaneous transluminal coronary angioplasty (PTCA) and intracoronary radiation therapy (ICRT): a possible new modality for the treatment of coronary restenosis—a preliminary report of the first 10 patients treated with intracoronary radiation therapy,” J. Am. College Cardiol. 0 (special issue), 288A (1995).
45.P. S. Teirstein, V. Massullo, S. Jani et al., “Catheter-based radiotherapy to inhibit restenosis after coronary stenting,” New England J. Med. 336, 16971703 (1997).
46.Y. Popowski, V. Verin, and P. Urban, “Endovascular beta-irradiation after percutaneous transluminal coronary balloon angioplasty,” Int. J. Radiat. Oncol., Biol., Phys. 36, 841845 (1996).
47.S. B. King, III, “The BERT (beta energy restenosis trial feasibility study),” Advances in Cardiovascular Radiation Therapy, presented by the Cardiology Research Foundation, Washington Hospital Center, Washington Cancer Institute, Course Directors, R. Waksman and M. B. Leon, Renaissance Washington, DC Hotel, Washington DC, 20–21 February 1997, pp. 164–166.
48.J. W. Moses, S. G. Ellis, S. R. Bailey, B. D. Raybuck, P. S. Teirstein, N. J. Weissman, and J. J. Popma, “Short term (1 month) results of the dose response IRIS feasibility study of a beta particle emitting radioisotope stent,” American College of Cardiology Meeting, March, 1998 (abstract).
49.A. S. Meigooni and R. Nath, “A comparison of radial dose functions for and brachytherapy sources,” Int. J. Radiat. Oncol., Biol., Phys. 22, 11251130 (1992).
50.R. Nath and L. Liu, “On the depth of penetration of photons and electrons for intravascular brachytherapy,” Med. Phys. 24, 1358 (1997) (abstract).
51.E. Browne and R. B. Firestone, Tables of Radioactive Isotopes (Wiley, New York, 1986).
52.R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, “Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43,” Med. Phys. 22, 209234 (1995).
53.H. I. Amols, M. Zaider, J. Weinberger, R. Ennis, P. B. Schiff, and L. E. Reinstein, “Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries,” Int. J. Radiat. Oncol., Biol., Phys. 36, 913921 (1996).
54.Z. Li, C. Liu, and J. R. Palta, “Dose distribution of stainless steel seeds at close distances,” submitted to the 1996 AAPM annual meeting, 1996.
55.Y. Popowski, V. Verin, I. Papirov et al., “High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation,” Int. J. Radiat. Oncol., Biol., Phys. 33, 211215 (1995).
56.C. G. Soares, D. G. Halpern, and C.-K. Wang, “Calibration and characterization of beta-particle sources for intravascular brachytherapy,” Med. Phys. 25, 339346 (1998).
57.Z. Xu, P. R. Almond, and J. O. Deasy, “The dose distribution produced by a source for endovascular irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 36, 933939 (1996).
58.K. K. Fessenden, J. I. DeMarco, T. D. Solberg, S. Rege, M. Razavi, J. B. Smathers, P. R. Almond, and Z. Xu, “Monte Carlo dosimetry for beta source selection and design for endovascular irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 36, 401 (1996) (abstract).
59.Y. Popowski, V. Verin, I. Papirov et al., “Intra-arterial Y-90 brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon,” Int. J. Radiat. Oncol., Biol., Phys. 33, 713717 (1995).
60.Y. Popowski, V. Verin, M. Schwager et al., “A novel system for intracoronary beta irradiation: description and dosimetric results,” Int. J. Radiat. Oncol., Biol., Phys. 36, 923931 (1996).
61.R. Loevinger, “Distribution of absorbed energy around a point source of beta radiation,” Science 112, 530531 (1950).
62.T. A. Fischell, K. K. Bassam, D. R. Fischell, P. G. Loges, C. W. Coffey, D. Duggan, and A. J. Naftilan, “Low-dose beta particle emission from ‘stent’ wire results in complete localized inhibition of smooth muscle cell proliferation,” Circulation 90, 29562963 (1994).
63.W. V. Prestwich, T. J. Kennett, and F. W. Kus, “The dose distribution produced by a P32-coated stent,” Med. Phys. 22, 313320 (1995).
64.W. V. Prestwich, “Analytic representation of the dose from a p-32-coated stent,” Med. Phys. 23, 913 (1996).
65.C. Coffey and D. Duggan, “Dosimetric considerations and dose measurement analysis of a p-32 radioisotope stent,” in Vascular Brachytherapy, edited by R. Waksman, S. King, I. A. Crocker, and R. F. Mould (Nucletron, Netherlands, 1996), pp. 207–216.
66.D. Duggan, C. Coffey, and S. Levit, “Point dose kernels for pure beta-emitting intracoronary brachytherapy stents theoretical models versus experimental methods using radiochromic dosimetry,” Int. J. Radiat. Oncol., Biol., Phys. 40, 713720 (1998).
67.C. Janicki, D. M. Duggan, C. W. Coffey, D. R. Fischell, and T. A. Fischell, “Radiation dose from a p-32 impregnated Palmaz–Schatz wire mesh vascular stent,” Med. Phys. 24, 437445 (1997).
68.C. Janicki, D. R. Fischell, K. Krumme, and M. Perry, “Application of the DPK model to predict the dose field around a p-32 advanced stent design,” Med. Phys. 24, 994 (1997) (abstract).
69.J. S. Whiting, A. N. Li, and N. Eigler, “3-D dose distributions for stents, liquid balloons, and y-90 seeds using dose-volume histograms,” Med. Phys. 24, 995 (1997) (abstract).
70.N. C. Ly, J. S. Whiting, A. DeFrance, and N. L. Eigler, “Novel brachytherapy source for treatment of coronary artery restenosis,” Med. Phys. 22, 925 (1995) (meeting abstract).
71.N. Li, N. L. Eigler, F. Litvack, and J. S. Whiting, “Characterization of a positron emitting V48-nitinol stent for intracoronary brachytherapy”, Med. Phys. 25, 2028 (1998).
72.H. I. Amols, L. E. Reinstein, and J. Weinberger, “Dosimetry of a radioactive coronary balloon dilitation catheter for treatment of neointimal hyperplasia,” Med. Phys. 23, 17831788 (1996).
73.H. D. Bottcher, B. Schopohl, D. Liermann, J. Kollath, and I. A. Adamietz, “Endovascular irradiation—a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results,” Int. J. Radiat. Oncol., Biol., Phys. 29, 183186 (1994).
74.H. J. van Kleffens and W. M. Star, “Application of stereo X-ray photogrammetry (SRM) in the determination of absorbed dose values during intracavitary radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 5, 557563 (1979).
75.J. F. Williamson and Z. Li, “Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate sources,” Med. Phys. 22, 809819 (1995).
76.R. W. Kline, M. T. Gillin, D. F. Grimm, and A. Niroomand-Rad, “Computer dosimetry of wire,” Med. Phys. 12, 634638 (1985).
77.J. A. Halbleib and T. A. Mehlhorn, ITS: The Integrated TIGER Series of Coupled Electron/Photon Monte Carlo Transport Codes, CCC-467, Radiation Information Shielding Center, Oak Ridge National Library, 1984.
78.ICRU Report No. 56, “Dosimetry of external beta rays for radiation protection,” International Commission on Radiation Units and Measurements, Bethesda, MD, 1997.
79.A. Rivard, G. Leclerc, M. Bouchard, C. Janicki, S. Roorda, G. Beaudoin, and R. Carrier, “Low dose beta-emitting radioactive stents inhibit neointimal hyperplasia in porcine coronary arteries: an IVUS assessment,” Circulation 94, I-210 (1996) (abstract).
80.A. Carter and J. R. Laird, “Experimental results with endovascular irradiation via a radioactive stent,” Int. J. Radiat. Oncol., Biol., Phys. 36, 797803 (1996).
81.C. Hehrlein, M. Stintz, R. Kinscherf, K. Schlosser, E. Huttel, L. Friedrich, P. Fehsenfeld, and W. Kubler, “Pure beta particle-emitting stents inhibit neointima formation in rabbits,” Circulation 93, 641645 (1996).
82.I. L. Larsen and D. A. Mohrbacher, “Analysis of p-32 labeled solutions using integrated bremsstrahlung radiation,” Radioactivity Radiochem. 3, 47 (1992).
83.M. J. Woods, A. S. Munster, J. P. Sephton, S. M. Lucas, and C. P. Walsh, “Calibration of the NPL secondary standard radionuclide calibrator for and Nucl. Instrum. Methods Phys. Res. 369, 698702 (1996).
84.B. M. Coursey and R. Colle, “Activity measurements of beta-particle emitting radionuclides for use in intravascular brachytherapy,” Med. Phys. 24, 994 (1997) (abstract).
85.G. J. Kutcher, L. Coia, M. Gillin et al., L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, “Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40,” Med. Phys. 21, 581618 (1994).
86.J. F. Williamson, “Practical quality assurance for low dose rate brachytherapy,” in Quality Assurance in Radiotherapy Physics, edited by G. Starkschall and L. Horton (Medical Physics Publishing, Madison, WI, 1991), pp. 139–182.
87.G. P. Glasgow, “Principles of brachytherapy quality assurance,” in Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadsen, and R. Nath (Medical Physics, Madison, WI, 1995), pp. 149–162.
88.G. P. Glasgow, J. D. Bourland, P. W. Grigsby, J. A. Meli, and K. A. Weaver, Remote Afterloading Technology, Report of the AAPM Radiation Therapy Committee Task Group No. 41, American Association of Physicists in Medicine, College Park, MD, 1993.
89.R. Nath, L. L. Anderson, J. A. Meli, A. J. Olch, J. A. Stitt, and J. F. Williamson, “Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56,” Med. Phys. 24, 15571598 (1997).

Data & Media loading...


Article metrics loading...


Full text loading...


Access Key

  • FFree Content
  • OAOpen Access Content
  • SSubscribed Content
  • TFree Trial Content
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd